Loading...
Morepen Laboratories Stock Jumps 15% on ₹825 Crore Global CDMO Deal
LIVE TV
LOCAL
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Loading more articles...
Home
Local
Live TV
Morepen Shares Soar 15% on ₹825 Crore Global CDMO Deal
C
CNBC TV18
•
23-02-2026, 10:16
Morepen Shares Soar 15% on ₹825 Crore Global CDMO Deal
•
Morepen Laboratories Limited shares surged over 14.5% after securing a multi-year Contract Development and Manufacturing Organisation (CDMO) mandate.
•
The deal, valued at approximately ₹825 crore, is with a leading global pharmaceutical company.
•
Supplies are expected to begin within 4-5 months, with execution through Q1 of the next financial year.
•
This mandate is one of the largest single CDMO contracts in Morepen's history, enhancing its global manufacturing scale.
•
The company is considering capacity enhancement and technology investments to support its growing CDMO pipeline.
Read Full Article on Cnbc in English
✦
More like this
✦
More like this
Morepen Labs Soars 15% on ₹825 Crore CDMO Deal Boost
M
Moneycontrol
KEC International Secures ₹1,002 Crore Orders, Stock Surges from 52-Week Low
C
CNBC Awaaz
Ipca Laboratories Shares Drop 2.11%; Among Top Nifty Midcap 150 Losers
M
Moneycontrol
Tembo Global Soars: Net Sales Up 75%, Profit Jumps 171% in Dec 2025 Quarter
M
Moneycontrol
Divis Labs Shares Dip 2.11% Amid High Volume Trading
M
Moneycontrol
Lincoln Pharma's Q3 Profit Jumps 38% to Rs 29 Cr, Revenue Up 13%
N
News18